Navigation Links
Connecticut's CURE network welcomes HLK, its first Chinese member company
Date:8/19/2013

HARTFORD, Conn., Aug. 19, 2013 /PRNewswire-iReach/ -- CURE, the Connecticut life and healthcare sciences network, has for the first time welcomed to its membership a Chinese bioscience company. The company, HLK (HLK Biotechnology Co., Ltd), aims to collaborate with CURE to act as a portal between the Connecticut and Chinese life sciences industries.

"Our goal is to bridge the West and the East in order to bring efficacious and safe medicines to patients in both countries," said co-founder and president Jun Xu. "After two years in China, we know how to navigate the hurdles of doing business in that country, with regard to working with government agencies and regulators. In addition, HLK has very strong technical capabilities in CMC and formulation development, and a wealth of knowledge at different stages of drug discovery and development."

Originally from Hunan Province, Ms. Xu is now a U.S. citizen and Connecticut resident with a family in Newtown. Her business partner, Dr. Zeren Wang, who is co-founder and managing director of the company, is originally from Shanghai, but is now also a U.S. citizen, living in Southbury. Both came to the U.S in the 1990s for academic training and later worked in research and development at Boehringer Ingelheim's U.S. headquarters in Ridgefield. Ms. Xu estimates the two now spend more than 80 percent of their time in China.

"I've known these two experienced pharma scientists for many years," said Dr. Peter R. Farina, who is a co-chair of CURE and was formerly senior vice president of development at Boehringer Ingelheim U.S. He is also chief scientific advisor to HLK. "Jun and Zeren are making personal sacrifices to pursue their dream, and they are doing so at an opportune time. As the Chinese economy continues to develop, access to the Chinese market is becoming increasingly important to life sciences companies. It is challenging for Westerners who want to develop drugs in China to know where to start or who to contact. Jun and Zeren understand US pharma standards and practices and can work with US firms to develop compounds for the Chinese healthcare market using state of the art pharmaceutical technology. At the same time, there is also growing interest in the U.S. in traditional Chinese medicine. HLK is looking at new ways of reformulating these therapeutics both for the Chinese and US markets."

HLK is headquartered in the high-tech industrial zone of Shenzhen, located in Guangdong province, just to the northwest of Hong Kong. Web address: http://hlkpharma.com/

"We're pleased to welcome HLK to the CURE community," said Susan Froshauer, Ph.D., president and CEO of CURE. "Our organization includes a number of member companies from outside of Connecticut, but this is our first from China. We look forward to partnering with HLK to help them expand their business activities to the U.S. and also to build out a U.S.-China portal. All our members have in common the recognition that Connecticut is growing in importance as a focal point of the life sciences industry in the U.S."

CURE (Connecticut United for Research Excellence) is the bioscience cluster of Connecticut, a diverse network of small and large life and health care sciences companies, universities, scientists, educators, students, entrepreneurs, mentors, business experts, and investors. Together we cultivate entrepreneurship, build bioscience companies, and collaborate to ensure a sustainable, high-value bioscience and healthcare community that improves our quality of life and keeps the Connecticut economy strong.

Media Contact: Bill Kelly, HarveyMalis Communications LLC, 203-375-2696, bill@harveymalis.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE CURE (Connecticut United for Research Excellence)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Device Developers - Network at BIOMEDevice Boston Next Week
2. Industry Veteran Brings Sales Expertise to AlloSources Growing Distribution Network
3. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
4. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
5. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
6. Medical Device Developers - Network at MD&M East Next Week
7. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine
8. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
9. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
10. The MED Group Expands MED Suppliers Network to add Ventilator Program
11. RxAlly Member Pharmacies Invited To Become The Preferred Network For Smart Insurance Company Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017  Novartis announced today that the ... the company,s Biologics License Application (BLA) filing and ... chimeric antigen receptor T cell (CAR-T) therapy, in ... patients with B-cell acute lymphoblastic leukemia (ALL). This ... a CAR-T. The priority review designation is expected ...
(Date:3/29/2017)... DUBLIN , Mar. 29, 2017 Research and ... Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast" ... ... 2021 from its current market size in 2016. The Untapped Proton Therapy ... than 1 Billion USD in 2016. Proton Therapy plays ...
(Date:3/29/2017)...  Zynex (OTCQB: ZYXI), an innovative medical technology company specializing ... for pain management, stroke rehabilitation, cardiac monitoring and neurological ... 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. ... expects to file its 2016 full year financial results ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... , ... March 30, 2017 , ... Grass pollen is the main cause of hay ... the stuff. The season for grass pollen runs from May to July each year; with ... fever victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense ...
(Date:3/29/2017)... ... ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower program in 2009 ... have participated in the program every summer. The 2017 Serve, Learn, & Empower ... Visit http://www.ghana.yfiexperience.org to learn more. , “I have sent my daughter ...
(Date:3/29/2017)... ... 30, 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale ... for the remaining days of March, the price will be only $19.97. The EXOUS ... of just $10 (regular retail price $19.97). , The special promotional prices are to ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... IN (PRWEB) , ... March 29, 2017 , ... ... Study, this webinar provides insight into the challenges employers face in trying to ... complexity of managing employee benefits programs? Adding to the growing complexity, companies ...
Breaking Medicine News(10 mins):